Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Amador

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|January 17, 2021
Commentary: Regional oncolytics for pleural malignanciesAlfredo Amador, Alexander J Byun, Prasad S Adusumilli
Translational Lung Cancer Research|April 11, 2024
DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: safety, efficacy, and challengesRebecca Y Bellis, Prasad S Adusumilli, Alfredo Amador-Molina
Cancers|October 31, 2018
Oncolytic Viruses for Canine Cancer TreatmentDiana Sánchez, Gabriela Cesarman-Maus, Alfredo Amador-Molina, et al.
Cancer Cell|April 29, 2022
Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumorsLeonid Cherkassky, Zhaohua Hou, Alfredo Amador-Molina, et al.
Viral Immunology|June 15, 2019
HPV18 E1 Protein Plus <i>α</i>-Galactosylceramide Elicit in Mice CD8<sup>+</sup> T Cell Cross-Reactivity Against Cells Expressing E1 from Diverse Human Papillomavirus TypesAlfredo Amador-Molina, Juan C Amador-Molina, Juan L Arciniega, et al.
The Journal of General Virology|October 27, 2012
Intratypic changes of the E1 gene and the long control region affect ori function of human papillomavirus type 18 variantsAlfredo Amador-Molina, José Luis González-Montoya, Alejandro García-Carrancá, et al.
Journal for Immunotherapy of Cancer|September 15, 2025
Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396)David Restle, Alfredo Amador-Molina, Kyohei Misawa, et al.
Viruses|October 31, 2013
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseAlfredo Amador-Molina, José Fernando Hernández-Valencia, Edmundo Lamoyi, et al.
Expert Opinion on Investigational Drugs|November 30, 2022
Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1Hue Tu Quach, Zhaohua Hou, Rebecca Y Bellis, et al.
Vaccine|February 2, 2019
Vaccination with human papillomavirus-18 E1 protein plus α-galactosyl-ceramide induces CD8<sup>+</sup> cytotoxic response and impairs the growth of E1-expressing tumorsAlfredo Amador-Molina, Cesar Trejo-Moreno, Damaris Romero-Rodríguez, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Thoracic and Cardiovascular Surgery|January 17, 2021
Commentary: Regional oncolytics for pleural malignanciesAlfredo Amador, Alexander J Byun, Prasad S Adusumilli
Translational Lung Cancer Research|April 11, 2024
DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: safety, efficacy, and challengesRebecca Y Bellis, Prasad S Adusumilli, Alfredo Amador-Molina
Cancers|October 31, 2018
Oncolytic Viruses for Canine Cancer TreatmentDiana Sánchez, Gabriela Cesarman-Maus, Alfredo Amador-Molina, et al.
Cancer Cell|April 29, 2022
Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumorsLeonid Cherkassky, Zhaohua Hou, Alfredo Amador-Molina, et al.
Viral Immunology|June 15, 2019
HPV18 E1 Protein Plus <i>α</i>-Galactosylceramide Elicit in Mice CD8<sup>+</sup> T Cell Cross-Reactivity Against Cells Expressing E1 from Diverse Human Papillomavirus TypesAlfredo Amador-Molina, Juan C Amador-Molina, Juan L Arciniega, et al.
The Journal of General Virology|October 27, 2012
Intratypic changes of the E1 gene and the long control region affect ori function of human papillomavirus type 18 variantsAlfredo Amador-Molina, José Luis González-Montoya, Alejandro García-Carrancá, et al.
Journal for Immunotherapy of Cancer|September 15, 2025
Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396)David Restle, Alfredo Amador-Molina, Kyohei Misawa, et al.
Viruses|October 31, 2013
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseAlfredo Amador-Molina, José Fernando Hernández-Valencia, Edmundo Lamoyi, et al.
Expert Opinion on Investigational Drugs|November 30, 2022
Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1Hue Tu Quach, Zhaohua Hou, Rebecca Y Bellis, et al.
Vaccine|February 2, 2019
Vaccination with human papillomavirus-18 E1 protein plus α-galactosyl-ceramide induces CD8<sup>+</sup> cytotoxic response and impairs the growth of E1-expressing tumorsAlfredo Amador-Molina, Cesar Trejo-Moreno, Damaris Romero-Rodríguez, et al.
Pageof 2